Prøve GULL - Gratis
Paid professional advice is expensive—until you skip it
Mint Mumbai
|August 14, 2025
An investor's decade-long journey shows the impact of trusted financial planning advisory
The number of Securities and Exchange Board of India-registered investment advisors (RIAs) is shrinking rapidly. Their number is down to just 970 from 1,300 a few years ago, according to Sebi data. Of these only 400 are active, industry sources say.
The main reasons are the huge compliance burden for RIAs and a lack of willingness among Indians to pay for professional financial advice. Sebi has been taking steps to ease the qualifying criteria and encourage more people to apply for an RIA licence, but for now they are a dying breed.
That's unfortunate, because generating returns is only part of an RIA's job. The other, equally if not more important, is keeping clients on track to meet goals by instilling financial discipline.
The story of Vishal Sharma, 51, an IT professional from Delhi, and his RIA of over 10 years illustrates this perfectly.
Lost at sea
In 2014, 72% of Sharma's portfolio was in real estate, along with six endowment insurance policies that offered poor returns. He knew little about equity or mutual funds. A friend introduced him to Nitin Sawant of NS Wealth after Sharma became a father, prompting him to take financial planning seriously. More than a decade later, he has met several goals and is on track for retirement. "I credit all my financial discipline to him," he said.
Portfolio clean-up
Denne historien er fra August 14, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

